
Epirubicin Hydrochloride Suppliers & Bulk Manufacturers
Available Forms: Injection (IV)
Available Strengths: 10 mg/5 mL, 50 mg/25 mL, 100 mg/50 mL
Reference Brands: Ellence® (US) , Farmorubicin®(EU)
Category: Oncology Cancer Care
Epirubicin Hydrochloride is available in Injection (IV) and strengths such as 10 mg/5 mL, 50 mg/25 mL, 100 mg/50 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Epirubicin Hydrochloride is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Epirubicin Hydrochloride can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Epirubicin Hydrochloride is a potent anthracycline chemotherapy agent widely used in treating breast, gastric, ovarian, lung, and bladder cancers. It works by inhibiting DNA synthesis, leading to effective cancer cell destruction. Available under brand names like Ellence® (US) and Farmorubicin® (EU), and in generic forms, Epirubicin is supplied as an IV injection in 10 mg, 50 mg, and 100 mg vial strengths. Manufactured in GMP-compliant facilities, it is ideal for hospital oncology departments and global pharmaceutical distributors. Epirubicin remains a trusted cancer treatment solution across EU and US markets, ensuring consistent quality and therapeutic efficacy.
Frequently Asked Questions
Related Products
Atezolizumab
Strength: 1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View DetailsDurvalumab
Strength: 120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View DetailsSunitinib
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers